Search

Your search keyword '"SACHER F"' showing total 1,023 results
Start Over Author "SACHER F"

Refine your results

1,023 results on '"SACHER F"'

51. Efficacy of deep sedation for patients with intractable electrical storm refractory to anti-arrhythmic drugs

Author

Martins, R, primary, Urien, J.M, additional, Barbarot, N, additional, Sellal, J.M, additional, Clementy, N, additional, Guenancia, C, additional, Gandjbakhch, E, additional, Duchateau, J, additional, Hamon, D, additional, Champ-Rigot, L, additional, Marijon, E, additional, Garcia, R, additional, De Chillou, C, additional, Sacher, F, additional, and Galand, V, additional

Published
2020
Full Text
View/download PDF

52. Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator

Author

Waldmann, V, primary, Bouzeman, A, additional, Duthoit, G, additional, Koutbi, R, additional, Bessiere, F, additional, Labombarda, F, additional, Marquie, C, additional, Gourraud, J.B, additional, Ladouceur, M, additional, Mondoly, P, additional, Sacher, F, additional, Iserin, L, additional, Thambo, J.B, additional, Combes, N, additional, and Marijon, E, additional

Published
2020
Full Text
View/download PDF

53. Thirty-day clinical outcomes after rhythmology procedures in patients with non-valvular atrial fibrillation on apixaban: Results of the AMPER AF study

Author

Amara, W., primary, Garcia, R., additional, Mansourati, J., additional, Taieb, J., additional, Gandjbackh, E., additional, Dompnier, A., additional, Gorka, H., additional, Zannad, N., additional, Da Costa, A., additional, Sacher, F., additional, Jourda, F., additional, Fromentin, S., additional, Cheggour, S., additional, Georger, F., additional, and Milhem, A., additional

Published
2020
Full Text
View/download PDF

54. Heparin and Low-Molecular-Weight Heparin switch associated with an increase in bleeding complications in patients on apixaban undergoing catheter ablation:The AMPER ABLATION Study

Author

Amara, W., primary, Garcia, R., additional, Mansourati, J., additional, Taieb, J., additional, Gandjbackh, E., additional, Dompnier, A., additional, Gorka, H., additional, Zannad, N., additional, Dacosta, A., additional, Sacher, F., additional, Jourda, F., additional, Fromentin, S., additional, Cheggour, S., additional, Georger, F., additional, and Milhem, A., additional

Published
2020
Full Text
View/download PDF

55. Real-world evidence of pacemaker and ICD implantation in patients taking apixaban: The French AMPER-AF implantation study

Author

Amara, W., primary, Mlayeh, D., additional, Garcia, R., additional, Mansourati, J., additional, Taieb, J., additional, Gandjbackh, E., additional, Dompnier, A., additional, Gorka, H., additional, Zannad, N., additional, Da Costa, A., additional, Sacher, F., additional, Jourda, F., additional, Fromentin, S., additional, Cheggour, S., additional, Georger, F., additional, and Milhem, A., additional

Published
2020
Full Text
View/download PDF

57. Everyday practice of cardioversion safety on apixaban: The French AMPER-AF cardioversion study

Author

Mlayeh, D., primary, Amara, W., additional, Garcia, R., additional, Mansourati, J., additional, Taieb, J., additional, Gandjbackh, E., additional, Dompnier, A., additional, Gorka, H., additional, Zannad, N., additional, Da Costa, A., additional, Sacher, F., additional, Jourda, F., additional, Fromentin, S., additional, Cheggour, S., additional, Georger, F., additional, and Milhem, A., additional

Published
2020
Full Text
View/download PDF

59. Freshwater ecosystems profit from activated carbon-based wastewater treatment across various levels of biological organisation in a short timeframe

Author

Triebskorn, R., Blaha, L., Gallert, C., Giebner, S., Hetzenauer, H., Köhler, H.-R., Kuch, B., Lüddeke, F., Oehlmann, J., Peschke, K., Sacher, F., Scheurer, M., Schwarz, S., Thellmann, P., Wurm, K., and Wilhelm, S.

Subjects
Chemical engineering, ddc:660
Abstract

Background Wastewater treatment plants are known as major sources for the release of micropollutants and bacteria into surface waters. To reduce this contaminant and microbial input, new technologies for effluent treatment have become available. The present paper reports the chemical, microbiological, biochemical, and biological effects of upgrading a wastewater treatment plant (WWTP) with a powdered activated carbon stage in the catchment area of the Schussen River, the largest German tributary of Lake Constance. Data were obtained prior to and after the upgrade between 2011 and 2017. Results After the upgrading, the release of antibiotic resistant and non-resistant bacteria, micropollutants, and their effect potentials was significantly lower in the effluent. In addition, in the Schussen River downstream of the wastewater treatment plant, reduced concentrations of micropollutants were accompanied by both a significantly improved health of fish and invertebrates, along with a better condition of the macrozoobenthic community. Conclusions The present study clearly provides evidence for the causality between a WWTP upgrade by powdered activated carbon and ecosystem improvement and demonstrates the promptness of positive ecological changes in response to such action. The outcome of this study urgently advocates an investment in further wastewater treatment as a basis for decreasing the release of micropollutants and both resistant and non-resistant bacteria into receiving water bodies and, as a consequence, to sustainably protect river ecosystem health and drinking water resources for mankind in the future.

Published
2019
Full Text
View/download PDF

63. International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome

Author

Clemens, D, Tester, D, Giudicessi, J, Bos, J, Rohatgi, R, Abrams, D, Balaji, S, Crotti, L, Faure, J, Napolitano, C, Priori, S, Probst, V, Rooryck-Thambo, C, Roux-Buisson, N, Sacher, F, Schwartz, P, Silka, M, Walsh, M, Ackerman, M, Clemens, DJ, Tester, DJ, Giudicessi, JR, Bos, JM, Rohatgi, RK, Abrams, DJ, Priori, SG, Schwartz, PJ, Silka, MJ, Walsh, MA, Ackerman, MJ, Clemens, D, Tester, D, Giudicessi, J, Bos, J, Rohatgi, R, Abrams, D, Balaji, S, Crotti, L, Faure, J, Napolitano, C, Priori, S, Probst, V, Rooryck-Thambo, C, Roux-Buisson, N, Sacher, F, Schwartz, P, Silka, M, Walsh, M, Ackerman, M, Clemens, DJ, Tester, DJ, Giudicessi, JR, Bos, JM, Rohatgi, RK, Abrams, DJ, Priori, SG, Schwartz, PJ, Silka, MJ, Walsh, MA, and Ackerman, MJ

Abstract

Background: Triadin knockout syndrome (TKOS) is a rare, inherited arrhythmia syndrome caused by recessive null mutations in TRDN-encoded cardiac triadin. Based previously on 5 triadin null patients, TKOS has been characterized by extensive T-wave inversions, transient QT prolongation, and severe disease expression of exercise-induced cardiac arrest in early childhood refractory to conventional therapy. Methods: We have established the International Triadin Knockout Syndrome Registry to include patients who have genetically proven homozygous/compound heterozygous TRDN null mutations. Clinical/genetic data were collected using an online survey generated through REDCap. Results: Currently, the International Triadin Knockout Syndrome Registry includes 21 patients (11 males, average age of 18 years) from 16 families. Twenty patients (95%) presented with either cardiac arrest (15, 71%) or syncope (5, 24%) at an average age of 3 years. Mild skeletal myopathy/proximal muscle weakness was noted in 6 (29%) patients. Of the 19 surviving patients, 16 (84%) exhibit T-wave inversions, and 10 (53%) have transient QT prolongation > 480 ms. Eight of 9 patients had ventricular ectopy on exercise stress testing. Thirteen (68%) patients have received implantable defibrillators. Despite various treatment strategies, 14 (74%) patients have had recurrent breakthrough cardiac events. Conclusion: TKOS is a potentially lethal disease characterized by T-wave inversions in the precordial leads, transient QT prolongation in some, and recurrent ventricular arrhythmias at a young age despite aggressive treatment. Patients displaying this phenotype should undergo TRDN genetic testing as TKOS may be a cause for otherwise unexplained cardiac arrest in young children. As gene therapy advances, enrollment into the International Triadin Knockout Syndrome Registry is encouraged to better understand TKOS and to ready a well-characterized cohort for future TRDN gene therapy trials.

Published
2019

65. Characteristics of scar-related ventricular tachycardia circuits using ultra-high-density mapping

Author

Martin, R, Maury, P, Bisceglia, C, Wong, T, Estner, H, Meyer, C, Dallet, C, Martin, CA, Shi, R, Takigawa, M, Rollin, A, Frontera, A, Thompson, N, Kitamura, T, Vlachos, K, Wolf, M, Cheniti, G, Duchâteau, J, Massoulié, G, Pambrun, T, Denis, A, Derval, N, Hocini, M, Della Bella, P, Haïssaguerre, M, Jaïs, P, Dubois, R, and Sacher, F

Subjects
catheters, animal structures, coronary sinus, Cardiovascular System & Hematology, urogenital system, anisotropy, heart disease, tachycardia
Abstract

BACKGROUND: Ventricular tachycardia (VT) with structural heart disease is dependent on reentry within scar regions. We set out to assess the VT circuit in greater detail than has hitherto been possible, using ultra-high-density mapping. METHODS: All ultra-high-density mapping guided VT ablation cases from 6 high-volume European centers were assessed. Maps were analyzed offline to generate activation maps of tachycardia circuits. Topography, conduction velocity, and voltage of the VT circuit were analyzed in complete maps. RESULTS: Thirty-six tachycardias in 31 patients were identified, 29 male and 27 ischemic. VT circuits and isthmuses were complex, 11 were single loop and 25 double loop; 3 had 2 entrances, 5 had 2 exits, and 15 had dead ends of activation. Isthmuses were defined by barriers, which included anatomic obstacles, lines of complete block, and slow conduction (in 27/36 isthmuses). Median conduction velocity was 0.08 m/s in entrance zones, 0.29 m/s in isthmus regions ( P

Published
2018

66. P1899Heparin and low-molecular-weight heparin switch associated with an increase in bleeding complications in patients on apixaban undergoing catheter ablation: The AMPER ABLATION study

Author

Amara, W, primary, Garcia, R, additional, Mansourati, J, additional, Taieb, J, additional, Gandjbackh, E, additional, Dompnier, A, additional, Gorka, H, additional, Zannad, N, additional, Da Costa, A, additional, Sacher, F, additional, Jourda, F, additional, Fromentin, S, additional, Cheggour, S, additional, Mlayeh, D, additional, and Milhem, A, additional

Published
2019
Full Text
View/download PDF

68. 5164New risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies

Author

Wahbi, K, primary, Ben Yaou, R, additional, Gandjbakhch, E, additional, Anselme, F, additional, Gossios, T, additional, Lakdawala, N, additional, Stalens, C, additional, Sacher, F, additional, Babuty, D, additional, Charron, P, additional, Vigouroux, C, additional, Bonne, G, additional, Kumar, S, additional, Elliott, P, additional, and Duboc, D, additional

Published
2019
Full Text
View/download PDF

69. P5694Outcomes of patients with arrhythmogenic right ventricular cardiomyopathy after ventricular tachycardia ablation without an implantable cardioverter-defibrillator: a multicenter international study

Author

Gandjbakhch, E, primary, Laredo, M, additional, Berruezo, A, additional, Gourraud, J B, additional, Martins, R, additional, Wong, T, additional, Sellal, J M, additional, Sacher, F, additional, Pison, L, additional, Pruvot, E, additional, Kumar, S, additional, Dellabella, P, additional, and Maury, P, additional

Published
2019
Full Text
View/download PDF

70. P5027Prognosis and evaluation of the risk markers of arrhythmia in a large population of Brugada syndrome patients

Author

Probst, V, primary, Anys, S, additional, Sacher, F, additional, Briand, J, additional, Guyomarch, B, additional, Tixier, R, additional, Berthome, P, additional, Babuty, D, additional, Thollet, A, additional, Mansourati, J, additional, Dupuis, J M, additional, Wiart, F, additional, Mabo, P, additional, Behar, N, additional, and Gourraud, J B, additional

Published
2019
Full Text
View/download PDF

71. P6585Number of ECG leads and prognosis of spontaneous type 1 Brugada syndrome

Author

Probst, V, primary, Arnaud, M, additional, Behar, N, additional, Mabo, P, additional, Guyomarch, B, additional, Tixier, R, additional, Briand, J, additional, Berthome, P, additional, Mansourati, J, additional, Babuty, D, additional, Maury, P, additional, Clerici, G, additional, Thollet, A, additional, Sacher, F, additional, and Gourraud, J B, additional

Published
2019
Full Text
View/download PDF

72. P6565The relation between the variation of CL and atrial tachycardia

Author

Takigawa, M T, primary, Andre, C A, additional, Lam, A L, additional, Escande, W E, additional, Nakatani, Y N, additional, Zeng, L Z, additional, Duchateau, J D, additional, Pambrun, T P, additional, Denis, A D, additional, Hocini, M H, additional, Sacher, F S, additional, Jais, P J, additional, Haissaguerre, M H, additional, and Derval, N D, additional

Published
2019
Full Text
View/download PDF

74. P2279First clinical evaluation of subcutaneous implantable cardiac defibrillator in Brugada patients

Author

Probst, V, primary, Clerici, G, additional, Babuty, D, additional, Badenco, N, additional, Marquie, C, additional, Leenhardt, A, additional, Maury, P, additional, Blangy, H, additional, Deharo, J C, additional, Tfelt-Hansen, J, additional, Rudic, B, additional, Behar, N, additional, Mansourati, J, additional, Sacher, F, additional, and Gourraud, J B, additional

Published
2019
Full Text
View/download PDF

75. 5201Intra-cardiac thrombus in patients undergoing ventricular tachycardia ablation. a computed tomographic scan study

Author

Sacher, F, primary, Roumegou, P, additional, Duchateau, J, additional, Derval, N, additional, Denis, A, additional, Pambrun, T, additional, Escande, W, additional, Takigawa, M, additional, Lam, A, additional, Andre, C, additional, Chauvel, R, additional, Hocini, M, additional, Haissaguerre, M, additional, Jais, P, additional, and Cochet, H, additional

Published
2019
Full Text
View/download PDF

76. Trastornos del ritmo auricular

Author

Pambrun, T., primary, Denis, A., additional, Derval, N., additional, Duchateau, J., additional, Klotz, N., additional, Sacher, F., additional, Jaïs, P., additional, Haïssaguerre, M., additional, and Hocini, M., additional

Published
2019
Full Text
View/download PDF

79. Cardiac Rhythm Disturbances in Hemodialysis Patients: Early Detection Using an Implantable Loop Recorder and Correlation With Biological and Dialysis Parameters

Author

SACHER, F., JESEL, L., BORNI-DUVAL, C., DE PRECIGOUT, V., LAVAINNE, F., BOURDENX, J. P., HADDJ-ELMRABET, A., SEIGNEURIC, B., KELLER, A., OTT, J., SAVEL, H., DELMAS, Y., BAZIN-KARA, D., KLOTZ, N., PLOUX, S., BUFFLER, S., RITTER, P., RONDEAU, Virginie, BORDACHAR, P., MARTIN, C., DEPLAGNE, A., REUTER, S., HAISSAGUERRE, M., GOURRAUD, J. B., VIGNEAU, C., MABO, P., MAURY, P., HANNEDOUCHE, T., BENARD, Antoine, and COMBE, C.

Subjects
Male, Death, Sudden, Cardiac, Renal Dialysis, Electrocardiography, Ambulatory, Humans, Arrhythmias, Cardiac, Female, Prospective Studies, Middle Aged, Aged, Electrodes, Implanted
Abstract

The aim of this study was to identify using implantable loop recorder (ILR) monitoring the mechanisms leading to sudden death (SD) in patients undergoing hemodialysis (HD).SD accounts for 11% to 25% of death in HD patients.Continuous rhythm monitoring was performed using the remote monitoring capability of the ILR device in patients undergoing HD at 8 centers. Clinical, biological, and technical HD parameters were recorded and analyzed.Seventy-one patients (mean age 65 ± 9 years, 73% men) were included. Left ventricular ejection fraction was 50% in 16%. Twelve patients (17%) had histories of atrial fibrillation or flutter at inclusion. During a mean follow-up period of 21.3 ± 6.9 months, 16 patients died (14% patient-years), 7 (44%) of cardiovascular causes. Four SDs occurred, with progressive bradycardia followed by asystole. The incidence of patients presenting with significant conduction disorder and with ventricular arrhythmia was 14% and 9% patient-years, respectively. In multivariate survival frailty analyses, a higher risk for conduction disorder was associated with plasma potassium5.0 mmol/l, bicarbonate 22 mmol/l, hemoglobin11.5 g/dl, pre-HD systolic blood pressure140 mm Hg, the longer interdialytic period, history of coronary artery disease, previous other arrhythmias, and diabetes mellitus. A higher risk for ventricular arrhythmia was associated with potassium 4.0 mmol/l, no antiarrhythmic drugs, and previous other arrhythmias. With ILR monitoring, de novo atrial fibrillation or flutter was diagnosed in 14 patients (20%).ILR may be considered in HD patients prone to significant conduction disorders, ventricular arrhythmia, or atrial fibrillation or flutter to allow early identification and initiation of adequate treatment. Therapeutic strategies reducing serum potassium variability could decrease the rate of SD in these patients. (Implantable Loop Recorder in Hemodialysis Patients [RYTHMODIAL]; NCT01252823).

Published
2017

80. Ventricular arrhythmias and sudden death in tetralogy of Fallot

Author

Maury, P., Sacher, F., Rollin, A., Mondoly, P., Duparc, A., Zeppenfeld, K., Hascoet, S., and Reseau Francophone Rythmolo

Subjects
medicine.medical_specialty, medicine.medical_treatment, Electric Countershock, 030204 cardiovascular system & hematology, Ablation, Ventricular tachycardia, Risk Assessment, Sudden death, Sudden cardiac death, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Preventive Health Services, medicine, Humans, 030212 general & internal medicine, Tetralogy of Fallot, business.industry, General Medicine, Reentry, Implantable cardioverter-defibrillator, medicine.disease, Defibrillators, Implantable, Surgery, GUCH, Death, Sudden, Cardiac, Treatment Outcome, Catheter Ablation, Tachycardia, Ventricular, cardiovascular system, Cardiology, Cardiology and Cardiovascular Medicine, business, Anti-Arrhythmia Agents
Abstract

Malignant ventricular arrhythmias and sudden cardiac death may late happen in repaired tetralogy of Fallot, although probably less frequently than previously thought, especially with the advent of new surgical techniques/management. Ventricular tachycardias are caused by reentry around the surgical scars/patches and valves. Many predictive factors have been proposed, which suffer from poor accuracy. There is currently no recommended indication for prophylactic implantable cardioverter defibrillator implantation-except maybe in the case of multiple risk factors-while radiofrequncy ablation may be proposed in secondary prevention with or even without a back-up implantable cardioverter defibrillator in selected cases. Repeated cardiological investigations and monitoring should be proposed for every operated patient.

Published
2017

81. P4850Variability in the diagnosis of Brugada syndrome

Author

Plessis, M, primary, Sacher, F, additional, Behar, N, additional, Mabo, P, additional, Belhassen, B, additional, Ackerman, M J, additional, Schulze-Bahr, E, additional, Viskin, S, additional, Probst, V, additional, and Gourraud, J B, additional

Published
2018
Full Text
View/download PDF

83. 3298First clinical evaluation of subcutaneous implantable cardiac defibrillator in brugada patients

Author

Probst, V, primary, Clerici, G, additional, Babuty, D, additional, Badenco, N, additional, Marquie, C, additional, Leenhardt, A, additional, Maury, P, additional, Blangy, H, additional, Deharo, J L, additional, Tfelt-Hansen, J, additional, Rudic, B, additional, Behar, N, additional, Mansourati, J, additional, Sacher, F, additional, and Gourraud, J B, additional

Published
2018
Full Text
View/download PDF

87. 223Early post-operative ventricular arrhythmias increase mortality in patient with continuous-flow left ventricular assist device

Author

Galand, V, primary, Leclercq, C L, additional, Boule, S B, additional, Mondoly, P M, additional, Sacher, F S, additional, Kindo, M K, additional, Rouviere, P R, additional, Gourraud, J B, additional, Defaye, P D, additional, Verdonk, C V, additional, Anselme, F A, additional, Pierre, B P, additional, Eschallier, R E, additional, Marijon, E M, additional, and Martins, RPM, additional

Published
2018
Full Text
View/download PDF

88. P1173Repeated ablation of atrial fibrillation with ultra-high density mapping: workflow and validation in clinical practice. Insights from the TRUE HD study

Author

Garcia-Bolao, J I, primary, Mcelderry, T, additional, Weiner, S, additional, Jais, P, additional, Wong, T, additional, Maddox, W, additional, Ji, S Y, additional, Sacher, F, additional, Willems, S, additional, Mounsey, J, additional, Maury, P, additional, Bollmann, A, additional, Tung, R, additional, Raciti, G, additional, and Hindricks, G, additional

Published
2018
Full Text
View/download PDF

89. 689Prediction of termination/conversion and subsequent second circuit of atrial tachycardia

Author

Takigawa, M T, primary, Derval, N D, additional, Frontera, A F, additional, Vlachos, K V, additional, Kitamura, T K, additional, Chenit, G C, additional, Duchateau, J D, additional, Martin, C M, additional, Klotz, N K, additional, Pambrun, T P, additional, Denis, A D, additional, Sacher, F S, additional, Hocini, M H, additional, Haissaguerre, M H, additional, and Jais, P J, additional

Published
2018
Full Text
View/download PDF

90. 527Safety and acute effectiveness of the 3D RHYTHMIA mapping system for ablation of arrhythmias: results of the TRUE-HD study

Author

Hindricks, G, primary, Weiner, S, additional, Jais, P, additional, Wong, T, additional, Maddox, W, additional, Garcia-Bolao, I J, additional, Ji, S Y, additional, Sacher, F, additional, Willems, S, additional, Mounsey, J P, additional, Maury, P, additional, Bollmann, A, additional, Tung, R, additional, Raciti, G, additional, and Mcelderry, T, additional

Published
2018
Full Text
View/download PDF

91. 519Are recurrences of post MI VT due to substrate progression of insufficient index ablation? A 4 years FU study

Author

Lam, A, primary, Wolf, M, additional, Kitamura, T, additional, Takigawa, M, additional, Martin, C, additional, Bourier, F, additional, Frontera, A, additional, Sacher, F, additional, Derval, N, additional, Denis, A, additional, Pambrun, T, additional, Duchateau, J, additional, Hochini, M, additional, Haissaguerre, M, additional, and Jais, P, additional

Published
2018
Full Text
View/download PDF

92. 1074Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices

Author

Galand, V, primary, Leclercq, C L, additional, Boule, S B, additional, Mondoly, P M, additional, Sacher, F S, additional, Kindo, M K, additional, Rouviere, P R, additional, Gourraud, J B, additional, Defaye, P D, additional, Anselme, F A, additional, Pierre, B P, additional, Eschallier, R E, additional, Marijon, E M, additional, and Martins, RPM, additional

Published
2018
Full Text
View/download PDF

93. Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients

Author

Denis, A, primary, Sacher, F, additional, Derval, N, additional, Martin, R, additional, Lim, H S, additional, Pambrun, T, additional, Massoullie, G, additional, Duchateau, J, additional, Cochet, H, additional, Pillois, X, additional, Cheniti, G, additional, Frontera, A, additional, Takigawa, M, additional, Vlachos, K, additional, Martin, C, additional, Kitamura, T, additional, Hocini, M, additional, Douard, H, additional, Jaïs, P, additional, and Haïssaguerre, M, additional

Published
2018
Full Text
View/download PDF

96. 37Effect of activation wavefront on electrogram characteristics during ventricular tachycardia ablation

Author

Martin, CA, primary, Martin, R, additional, Wong, T, additional, Maury, P, additional, Dallet, C, additional, Takigawa, M, additional, Frontera, A, additional, Cheniti, G, additional, Thompson, N, additional, Massouillie, G, additional, Kitamura, T, additional, Wolf, M, additional, Duchateau, J, additional, Vlachos, K, additional, Pambrun, T, additional, Denis, A, additional, Derval, N, additional, Hocini, M, additional, Haissaguerre, M, additional, Jais, P, additional, and Sacher, F, additional

Published
2017
Full Text
View/download PDF

97. 073_16988-H2 Electrogram Signature of Specific Activation Patterns: Analysis of Atrial Arrhythmias at High-Density Endocardial Mapping

Author

Frontera, A., primary, Takigawa, M., additional, Martin, R., additional, Thompson, N., additional, Cheniti, G., additional, Massouille, G., additional, Duchateau, J., additional, Kitamura, T., additional, Wolf, M., additional, Al-Jefairi, N., additional, Vlachos, K., additional, Yamashita, S., additional, Denis, A., additional, Hocini, M., additional, Cochet, H., additional, Sacher, F., additional, Jaïs, P., additional, Derval, N., additional, and Haïssaguerre, M., additional

Published
2017
Full Text
View/download PDF

99. 073_16987-H2 EGM Fractionation in Apparently Healthy Tissue: Time to Redefine the Voltage Threshold for Diseased Atrium?

Author

Frontera, A., primary, Martin, R., additional, Takigawa, M., additional, Cheniti, G., additional, Dallet, C., additional, Kitamura, T., additional, Thompson, N., additional, Wolf, M., additional, Massoullie, G., additional, Vlachos, K., additional, Denis, A., additional, Hocini, M., additional, Cochet, H., additional, Sacher, F., additional, Jaïs, P., additional, Derval, N., additional, and Haïssaguerre, M., additional

Published
2017
Full Text
View/download PDF

100. 77USe of ultra-high density activation mapping to aid isthmus identification in atrial macro-reentrant tachycardias in complex congenital heart disease

Author

Martin, CA, primary, Sawhney, V, additional, Martin, R, additional, Takigawa, M, additional, Frontera, A, additional, Cheniti, G, additional, Thompson, N, additional, Massouillie, G, additional, Kitamura, T, additional, Wolf, M, additional, Duchateau, J, additional, Vlachos, K, additional, Denis, A, additional, Pambrun, T, additional, Sacher, F, additional, Hocini, M, additional, Jais, P, additional, Haissaguerre, M, additional, Ezzat, V, additional, Lowe, MD, additional, and Derval, N, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results